Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin

Virology

Volumn 325, Issue 2, 2004, Pages 425-431

  Bell, Edward ^a   Shamim, Mohammad ^a   Whitbeck, J Charles ^a   Sfyroera, Georgia ^a   Lambris, John D ^a   Isaacs, Stuart N ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B5R; EEV; Extracellular enveloped virus; Neutralization tests; Vaccination complications; Vaccinia immune globulin; Vaccinia virus; VIG; Virus neutralization

Indexed keywords

IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; PROTEIN B5R; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VACCINIA ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VACCINIA VIRUS; VIRUS CULTURE; VIRUS NEUTRALIZATION; VIRUS PLAQUE; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BIOTERRORISM; HUMANS; IMMUNOGLOBULINS; MEMBRANE GLYCOPROTEINS; MUTAGENESIS; NEUTRALIZATION TESTS; SMALLPOX VACCINE; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS;

VACCINIA VIRUS; VARIOLA VIRUS;

EID: 3142604952     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.05.004     Document Type: Article

References (25)

1. Appleyard G., Hapel A.J., Boulter E.A. An antigenic difference between intracellular and extracellular rabbitpox virus. J. Gen. Virol. 13:1971;9-17
2. Barbero G.J., Gray A., Scott T.F., Kempe C.H. Vaccinia gangrenosa treated with hyperimmune vaccinal gamma globulin. Pediatrics. 16:1955;609-618
3. Earl P.L., Americo J.L., Wyatt L.S., Eller L.A., Whitbeck J.C., Cohen G.H., Eisenberg R.J., Hartmann C.J., Jackson D.L., Kulesh D.A., Martinez M.J., Miller D.M., Mucker E.M., Shamblin J.D., Zwiers S.H., Huggins J.W., Jahrling P.B., Moss B. Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox. Nature. 428:2004;182-185
4. Engelstad M., Smith G.L. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology. 194:1993;627-637
5. Engelstad M., Howard S.T., Smith G.L. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology. 188:1992;801-810
6. Galmiche M.C., Goenaga J., Wittek R., Rindisbacher L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology. 254:1999;71-80
7. Goldsmith J.C., Eller N., Mikolajczyk M., Manischewitz J., Golding H., Scott D.E. Intravenous immunoglobulin products contain neutralizing antibodies to vaccinia. Vox Sang. 86(2):2004;125-129
8. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., Hanifin J.M., Slifka M.K. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9(9):2003;1131-1137
9. Herrera E., Lorenzo M.M., Blasco R., Isaacs S.N. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain. J. Virol. 72:1998;294-302
10. Hooper J.W., Custer D.M., Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology. 306(1):2003;181-195
11. Hooper J.W., Thompson E., Wilhelmsen C., Zimmerman M., Ichou M.A., Steffen S.E., Schmaljohn C.S., Schmaljohn A.L., Jahrling P.B. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J. Virol. 78(9):2004;4433-4443
12. Ichihashi Y., Takahashi T., Oie M. Identification of a vaccinia virus penetration protein. Virology. 202:1994;834-843
13. Isaacs S.N., Wolffe E.J., Payne L.G., Moss B. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope. J. Virol. 66:1992;7217-7224
14. Kempe C.H., Berge T.O., England B. Hyperimmune vaccinal gamma globulin: source, evaluation, and use in prophylaxis and therapy. Pediatrics. 18:1956;177-188
15. Law M., Smith G.L. Antibody neutralization of the extracellular enveloped form of vaccinia virus. Virology. 280(1):2001;132-142
16. Law M., Hollinshead R., Smith G.L. Antibody-sensitive and antibody-resistant cell-to-cell spread by vaccinia virus: role of the A33R protein in antibody-resistant spread. J. Gen. Virol. 83(Pt 1):2002;209-222
17. Mathew E., Sanderson C.M., Hollinshead M., Smith G.L. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation. J. Virol. 72:1998;2429-2438
18. Payne L.G. Significance of extracellular virus in the in vitro and in vivo dissemination of vaccinia virus. J. Gen. Virol. 50:1980;89-100
19. Rux A.H., Willis S.H., Nicola A.V., Hou W., Peng C., Lou H., Cohen G.H., Eisenberg R.J. Functional region IV of glycoprotein D from herpes simplex virus modulates glycoprotein binding to the herpesvirus entry mediator. J. Virol. 72(9):1998;7091-7098
20. Smith G.L., Vanderplasschen A. Extracellular enveloped vaccinia virus. Entry, egress, and evasion. Adv. Exp. Med. Biol. 440:1998;395-414
21. Sussman M.D. Complications of smallpox vaccination. Effects of vaccinia immune globulin therapy. J. Pediatr. 67:1965;1168-1173
22. Vanderplasschen A., Hollinshead M., Smith G.L. Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J. Gen. Virol. 79:1998;877-887
23. Vanderplasschen A., Mathew E., Hollinshead M., Sim R.B., Smith G.L. Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc. Natl. Acad. Sci. 95:1998;7544-7549
24. Wolffe E.J., Isaacs S.N., Moss B. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination. J. Virol. 67:1993;4732-4741
25. Wolffe E.J., Vijaya S., Moss B. A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies. Virology. 211:1995;53-63